(Q24187890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

title

Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

0 references

1 reference

Kristin Carson-Chahhoud

3

object named as

Kristin V Carson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Khin Hnin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Chau Nguyen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David J Evans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Michael Greenstone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Brian J Smith

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

13 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

CD001392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Treatment With tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Antibiotic therapy in infections of the respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Factors associated with respiratory insufficiency in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effect of antibiotics on purulent sputum in chronic bronchitis and bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Chloramphenicol treatment of bronchiectasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Antibiotics and purulent sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Erythromycin therapy for otitis media with effusion in sinobronchial syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Nebulised taurolidine and B cepacia bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Acapella versus 'usual airway clearance' during acute exacerbation in bronchiectasis: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Cefuroxime in severe respiratory infections: A double-blind comparison of two doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Daily single-dose regimen and alternate-two-week triple-dose/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Comparison of chest X-ray findings and other parameters in acute exacerbation of chronic bronchitis in Japan and the West

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Efficacy of azithromycin in the treatment of bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The bronchiectasis severity index. An international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Airway microbiology and host defences in paediatric non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The pathophysiology of bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Mortality in bronchiectasis: a long-term study assessing the factors influencing survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Non-cystic fibrosis bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

British Thoracic Society guideline for non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Reduction in bronchial subdivision in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The evidence base for non-CF bronchiectasis is finally evolving

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

New Zealand national incidence of bronchiectasis "too high" for a developed country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Prolonged antibiotics for purulent bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Prolonged antibiotics for purulent bronchiectasis in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001392.PUB3

Penetration of antibiotics into the respiratory tract

21 January 2018

1 reference

12 December 2020

Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis

1 reference

12 December 2020

Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study

1 reference

12 December 2020

Direct current in the overall treatment of inflammatory suppurative diseases of the lungs

1 reference

12 December 2020

[Intratracheal use of morphocycline]

1 reference

12 December 2020

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.

1 reference

12 December 2020

Chronic bronchitis; an attempt to control chronic infection with Haemophilus influenzae by aerosol therapy

1 reference

12 December 2020

Effect of bromhexeine on sputum amoxycillin levels in lower respiratory infections

1 reference

12 December 2020

[Clinical trials of netilmicin against respiratory tract infection].

1 reference

12 December 2020

Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients

1 reference

12 December 2020

[Cleansing of the bronchial tree in treating chronic inflammatory lung diseases]

1 reference

12 December 2020

[Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases. A controlled study]

1 reference

12 December 2020

Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis

1 reference

12 December 2020

Comparative study of the clinical activity of tetracycline and a combinaton of tetracycline and thiamphenicol in respiratory tract infections. Controlled study of a cooperative type

1 reference

12 December 2020

Amoxycillin in the treatment of chronic non-tuberculous bronchial infections

1 reference

12 December 2020

Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract

1 reference

12 December 2020

Pseudomonas aeruginosa in hospitalized patients with infective exacerbations of bronchiectasis: Clinical and research implications

1 reference

12 December 2020

[Impact of treatment with low dose roxithromycin on stable bronchiectasis]

1 reference

12 December 2020

Long-term oxytetracycline (terramycin) therapy in advanced chronic respiratory infections

1 reference

12 December 2020

[Clinical study of a new cephalosporin: ceftriaxone (RO 13-9904) in resurgent acute and chronic bronchopneumopathies]

1 reference

12 December 2020

Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis

1 reference

12 December 2020

Evaluation of imipenem/cilastatin sodium in the treatment of respiratory tract infections

1 reference

12 December 2020

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis

1 reference

12 December 2020

A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis

1 reference

12 December 2020

Use of combinations of trimethoprim and sulphamethoxazole in the treatment of chest infections.

1 reference

12 December 2020

A comparative study of ofloxacin twice and three times daily in the treatment of respiratory tract infections

1 reference

12 December 2020

[Comparative evaluation of various antibiotics and Biseptol in the treatment of exacerbation of chronic bronchial diseases]

1 reference

12 December 2020

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study

1 reference

12 December 2020

Antibiotic therapy of suppurative-inflammatory lesions of the bronchi with endobronchial use of low-frequency ultrasonic energy

1 reference

12 December 2020

Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection

1 reference

12 December 2020

[Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract]

1 reference

12 December 2020

Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity

1 reference

12 December 2020

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial

1 reference

12 December 2020

Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases

1 reference

12 December 2020

The response of patients with purulent bronchiectasis to antibiotics for four months

1 reference

12 December 2020

Bronchiectasis in indigenous children in remote Australian communities

1 reference

12 December 2020

Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register

1 reference

12 December 2020

[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology]

1 reference

12 December 2020

Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.

1 reference

12 December 2020

Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.

1 reference

12 December 2020

Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis

1 reference

12 December 2020

PROLONGED antibiotic treatment of severe bronchiectasis; a report by a subcommittee of the Antibiotics Clinical Trials (non-tuberculous) Committee of the Medical Research Council

1 reference

12 December 2020

[Double-blind study of the sulfamethoxazole-trimethoprim association in the treatment of pulmonary infections]

1 reference

12 December 2020

Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid

1 reference

12 December 2020

Amoxicillin in the treatment of lower respiratory infections

1 reference

12 December 2020

Use of miocamycin in respiratory tract diseases

1 reference

12 December 2020

Cefodizime once daily in the treatment of lower respiratory tract infections

1 reference

12 December 2020

Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)

1 reference

12 December 2020

Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections

1 reference

12 December 2020

Late results of the conservative treatment of bronchiectasis in adults

1 reference

12 December 2020

A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis

1 reference

12 December 2020

[Pulmonary function and quality of life in relation to bronchial colonization in adults with bronchiectasis not caused by cystic fibrosis]

1 reference

12 December 2020

The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia

1 reference

12 December 2020

[Clinical results of the use of cephaloridine in lung diseases, especially pulmonary tuberculosis]

1 reference

12 December 2020

Comparative studies on the toxicity of tetracyclines and chloramphenicol in the treatment of nonspecific bronchopulmonary infections

1 reference

12 December 2020

Surgical results in primary bronchiectasis

1 reference

12 December 2020

Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Treatment with Sumetrolim in chronic non-specific respiratory tract infections

1 reference

12 December 2020

[Effect of Inhalation of Tobramycin for 12 Months on Reduction of Hospitalisation Rate in Severe COPD]

1 reference

12 December 2020

Asian multicenter trial of cefoperazone in respiratory tract infection

1 reference

12 December 2020

Clinical trial use of phenoxypropyl penicillin

1 reference

12 December 2020

[Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections]

1 reference

12 December 2020

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis

1 reference

12 December 2020

Clinical evaluation of ciprofloxacin in pulmonary infections in the patients with chronic respiratory diseases

1 reference

12 December 2020

Nebulizer therapy with antibiotics in chronic suppurative lung disease

1 reference

12 December 2020

How to assess the severity of bronchiectasis

1 reference

12 December 2020

1 reference

12 December 2020

[Treatment of non-cystic fibrosis bronchiectasis]

1 reference

12 December 2020

Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease

1 reference

12 December 2020

Nebulized amoxicillin in chronic purulent bronchiectasis

1 reference

12 December 2020

Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis

1 reference

12 December 2020

Clinical studies on the utility of ofloxacin for lower respiratory infections

1 reference

12 December 2020

A comparison of cefotaxime and cefoperazone in respiratory tract infections

1 reference

12 December 2020

[Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections]

1 reference

12 December 2020

Chemotherapy of respiratory diseases

1 reference

12 December 2020

Corrections. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

1 reference

12 December 2020

[Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections]

1 reference

12 December 2020

The use of probenecid to increase the serum amoxycillin levels in patients with bronchiectasis

1 reference

12 December 2020

Inflammation: a two-edged sword--the model of bronchiectasis

1 reference

12 December 2020

Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies

1 reference

12 December 2020

Amoxicillin in the Treatment of Infections of the Lower Respiratory Tract

1 reference

12 December 2020

Inhaled gentamicin in non-cystic fibrosis bronchiectasis: effects of long-term therapy

1 reference

12 December 2020

Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis. Controlled trials of increasing dosage of cephaloridine

1 reference

12 December 2020

Effect and action mechanism of short-term administration of clarithromycin for airway hypersecretion

1 reference

12 December 2020

Long-term treatment of bronchlectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture

1 reference

12 December 2020

A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population

1 reference

12 December 2020

CLINICAL TRIALS OF THE NEW ANTIBIOTIC, RIFAMYCIN SV: PRELIMINARY REPORT

1 reference

12 December 2020

A pilot study of low-dose erythromycin in bronchiectasis

1 reference

12 December 2020

Bronchial inflammation and colonization in patients with clinically stable bronchiectasis

1 reference

12 December 2020

Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections

1 reference

12 December 2020

Antibiotic prophylaxis in chronic respiratory diseases

1 reference

12 December 2020

Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)

1 reference

12 December 2020

Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis

1 reference

12 December 2020

Bisolvomycin and Bisolvon in the treatment of chronic bronchitis, bronchial asthma and bronchiectasis

1 reference

12 December 2020

The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin

1 reference

12 December 2020

Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis

1 reference

12 December 2020

Cefuroxime and ampicillin compared in a double-blind study in the treatment of lower respiratory tract infections

1 reference

12 December 2020

Study of the Diffusion of Cefotiam in the Bronchial Secretions

1 reference

12 December 2020

Bronchiectasis - a guide for primary care.

1 reference

12 December 2020

Use of Combinations of Trimethoprim and Sulfamethoxazole in the Treatment of Chest Infections

1 reference

12 December 2020

Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis.

1 reference

12 December 2020

[Prophylactic administration of Bactrim in chronic bronchitis. A double blind clinical and biological study (author's transl)]

1 reference

12 December 2020

Clinical study on the efficacy of clofoctol in the treatment of infectious respiratory diseases

1 reference

12 December 2020

10.1002/14651858.CD001392.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270620%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

26270620

1 reference